Literature DB >> 31526550

Cancer and the Immune System: The History and Background of Immunotherapy.

Maura Abbott1, Yelena Ustoyev2.   

Abstract

OBJECTIVE: This article will outline the link between the immune system and cancer, and provide a historical timeline of immunotherapy developmental milestones. DATA SOURCES: Published data and peer reviewed publications/manuscripts, and textbook chapters.
CONCLUSION: Science has provided a greater understanding of the interactions between cancer and the human immune system. As this knowledge has grown, there has been significant progress in the development of clinically effective cancer immunotherapies. IMPLICATIONS FOR NURSING PRACTICE: Nurses' knowledge of the different types of immunity and the interaction of cancer cells with the immune system provides foundational knowledge for understanding cancer immunotherapy. Familiarity with the history of cancer immunotherapy will allow nurses to better comprehend why immunotherapy is now a pillar of cancer treatment that continues to develop. This knowledge will translate to better understanding and provision of care for patients receiving immunotherapy for the treatment of cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Cancer immunotherapy; History; Immunotherapy history; Innate immunity

Mesh:

Substances:

Year:  2019        PMID: 31526550     DOI: 10.1016/j.soncn.2019.08.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  48 in total

Review 1.  Advances in plant-derived natural products for antitumor immunotherapy.

Authors:  Yi Yang; Qinying Liu; Xianai Shi; Qiuhong Zheng; Li Chen; Yang Sun
Journal:  Arch Pharm Res       Date:  2021-11-09       Impact factor: 4.946

Review 2.  Latest research progress on anticancer effect of baicalin and its aglycone baicalein.

Authors:  Lin Wang; Ting Feng; Zhilian Su; Chao Pi; Yumeng Wei; Ling Zhao
Journal:  Arch Pharm Res       Date:  2022-07-31       Impact factor: 6.010

Review 3.  Functions and clinical applications of exosomes in pancreatic cancer.

Authors:  Zhichen Jiang; Huiju Wang; Yiping Mou; Li Li; Weiwei Jin
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

4.  Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.

Authors:  Xiaoguang Wang; Man Ni; Daxiong Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

Review 5.  Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.

Authors:  Zachary R Stephen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2020-11-25       Impact factor: 9.933

6.  Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.

Authors:  Na Li; Biao Li; Xianquan Zhan
Journal:  Front Genet       Date:  2021-02-10       Impact factor: 4.599

7.  Single-Cell Sequencing Analysis Based on Public Databases for Constructing a Metastasis-Related Prognostic Model for Gastric Cancer.

Authors:  Rubin Xu; Liang Chen; Wei Wei; Qikai Tang; You Yu; Yiming Hu; Sultan Kadasah; Jiaheng Xie; Hongzhu Yu
Journal:  Appl Bionics Biomech       Date:  2022-04-27       Impact factor: 1.664

Review 8.  Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases.

Authors:  Cameron Zamanian; Archis R Bhandarkar; Dileep D Monie; F M Moinuddin; Richard G Vile; Alfredo Quiñones-Hinojosa; Mohamad Bydon
Journal:  Neurosurg Focus       Date:  2022-02       Impact factor: 4.332

9.  Commonly Reported Adverse Events Associated With Pediatric Immunotherapy: A Systematic Review From the Children's Oncology Group

Authors:  Janice S Withycombe; Aimee Carlson; Carly Coleman; Sharon L Leslie; Micah Skeens; Hanna Tseitlin; Elizabeth A Duffy
Journal:  J Pediatr Oncol Nurs       Date:  2020-10-28       Impact factor: 1.636

Review 10.  Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy.

Authors:  Seokhwan Chung; Richard A Revia; Miqin Zhang
Journal:  Nanoscale Horiz       Date:  2021-07-20       Impact factor: 11.684

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.